FSM Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
4,589
-441
-9% -$94.9K 0.12% 99
2026
Q1
$1.09M Sell
5,030
-766
-13% -$170K 0.14% 88
2025
Q4
$1.32M Sell
5,796
-67
-1% -$15.3K 0.18% 72
2025
Q3
$1.36M Buy
5,863
+415
+8% +$84.5K 0.19% 71
2025
Q2
$1.02M Buy
5,448
+117
+2% +$21.7K 0.17% 89
2025
Q1
$1.12M Buy
5,331
+219
+4% +$42.6K 0.25% 57
2024
Q4
$888K Sell
5,112
-120
-2% -$22.1K 0.22% 63
2024
Q3
$1.03M Buy
5,232
+151
+3% +$28.2K 0.27% 56
2024
Q2
$872K Buy
5,081
+1,093
+27% +$181K 0.29% 57
2024
Q1
$726K Sell
3,988
-310
-7% -$53.4K 0.26% 66
2023
Q4
$666K Buy
4,298
+94
+2% +$13.7K 0.28% 65
2023
Q3
$627K Sell
4,204
-128
-3% -$18.8K 0.32% 65
2023
Q2
$587K Sell
4,332
-537
-11% -$78.7K 0.29% 72
2023
Q1
$776K Sell
4,869
-857
-15% -$131K 0.45% 47
2022
Q4
$925K Sell
5,726
-935
-14% -$143K 0.66% 38
2022
Q3
$894K Buy
6,661
+3,599
+118% +$516K 0.74% 38
2022
Q2
$430K Buy
+3,062
New +$468K 0.43% 64

Other funds holding ABBV

FSM Wealth Advisors's ABBV Position: Q2 2026 in Review

FSM Wealth Advisors reduced its AbbVie (ABBV) stake by 8.8% in Q2 2026, selling an estimated $94.9K and leaving 4,589 shares worth $1.15M. The position accounts for 0.12% of the portfolio, ranked #99.

FSM Wealth Advisors first reported a position in ABBV in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.36M in Q3 2025. 2,493 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • FSM Wealth Advisors held 4,589 shares of AbbVie worth $1.15M as of Q2 2026.
  • FSM Wealth Advisors sold 441 AbbVie shares in Q2 2026, an estimated $94.9K.
  • AbbVie made up 0.12% of FSM Wealth Advisors's portfolio in Q2 2026, its #99 holding.
  • FSM Wealth Advisors first reported a position in AbbVie in Q2 2022 and has held it in 17 quarters since.
  • FSM Wealth Advisors's AbbVie position peaked at $1.36M in Q3 2025.
  • 2,493 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on FSM Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.